Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Hemogenyx Pharmaceuticals Plc    SILF   GB00BYX3WZ24

HEMOGENYX PHARMACEUTICALS PLC

(SILF)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
9.5(c) 9.44(c) 9.3(c) 8.5(c) 8.2(c) Last
4 064 189 1 518 263 3 188 214 5 262 453 4 814 724 Volume
+2.70% -0.63% -1.48% -8.60% -3.53% Change
More quotes
Financials
Sales 2018 - - -
Net income 2018 -1,54 M -2,07 M -2,07 M
Net cash position 2018 0,59 M 0,79 M 0,79 M
P/E ratio 2018 -4,90x
Yield 2018 -
Sales 2019 - - -
Net income 2019 -1,45 M -1,94 M -1,94 M
Net Debt 2019 0,76 M 1,02 M 1,02 M
P/E ratio 2019 -4,85x
Yield 2019 -
Capitalization 35,6 M 47,6 M 47,6 M
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees 7
Free-Float 48,7%
More Financials
Company
Hemogenyx Pharmaceuticals Plc, formerly Silver Falcon Plc, is a biotechnology company. The Company is focused on developing new treatments for blood diseases such as leukaemia, lymphoma and blood marrow failure. Its therapies are designed to provide new treatments in bone marrow/stem cell transplants, improving the success and safety of such treatments. Its products include Conditioning and Cell therapy product.... 
More about the company
All news about HEMOGENYX PHARMACEUTICALS PLC
01/30HEMOGENYX PHARMACEUTICALS : Placing and Subscription to raise £650,000
PU
2017HEMOGENYX PHARMACEUTICALS PLC ("HEMO : LakePharma appointed as Service Provider ..
MW
2017SILVER FALCON : Result of General Meeting
PU
2017SILVER FALCON : Investor presentations
PU
2017SILVER FALCON : Final Results for the year ended 31 December 2016
PU
More news
News in other languages on HEMOGENYX PHARMACEUTICALS PLC

- No features available -

More news
Chart HEMOGENYX PHARMACEUTICALS PLC
Duration : Period :
Hemogenyx Pharmaceuticals Plc Technical Analysis Chart | SILF | GB00BYX3WZ24 | MarketScreener
Technical analysis trends HEMOGENYX PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Managers
NameTitle
Vladislav Sandler Chief Executive Officer & Executive Director
Marc Feldmann Executive Chairman
Alexis M. Sandler Non-Executive Director
Peter Redmond Non-Executive Director
Andrew Wright Secretary & Financial Controller
Sector and Competitors
1st jan.Capitalization (M$)
HEMOGENYX PHARMACEUTICALS PLC320.51%48
GILEAD SCIENCES, INC.-8.43%75 525
VERTEX PHARMACEUTICALS-0.39%56 298
REGENERON PHARMACEUTICALS35.38%53 416
WUXI APPTEC CO., LTD.55.32%38 761
BIONTECH SE209.80%24 529